文献速递神经介入DSA

Woven EndoBridge装置血管内治疗颅内动脉瘤的安全性与有效性

Endovascular treatment of intracranial aneurysms with the Woven EndoBridge- safety and efficacy.
PubMed 文献 · Neuroradiology · 2025-06-11

回顾性分析44例颅内动脉瘤的WEB装置治疗,平均瘤高7.1 mm、瘤宽5.8 mm、瘤颈3.6 mm、穹颈比1.6;11%(n=5)技术失败,12个月时95%(n=20)的动脉瘤达到充分闭塞,作者认为WEB是安全治疗选择,闭塞率与血流导向装置相当且无需双联抗血小板治疗。

要点

  • WEB装置治疗后12个月随访,95%(n=20)的动脉瘤达到充分闭塞。
  • 11%(n=5)的病例出现技术性植入失败,术中2例发生血栓栓塞事件但无后遗损害。
  • 作者认为WEB闭塞率与血流导向装置相当,且无需双联抗血小板治疗。

核心结论

  • 与其他治疗策略(夹闭、弹簧圈栓塞等)及文献已知并发症率相比,本结果提示WEB是安全的治疗选择;血管造影结果方面WEB的闭塞率与血管内血流导向装置相当,且无需双联抗血小板治疗。

研究设计与样本

  • 回顾性研究,在一家诊断与介入神经放射科识别出44个接受WEB治疗的颅内动脉瘤,平均瘤高7.1 mm、平均瘤宽5.8 mm、平均瘤颈直径3.6 mm、平均穹颈比1.6,纳入破裂与未破裂动脉瘤,采用WEB闭塞量表在术后即刻及3、6、12个月随访评估闭塞。

诊断标准与关键数值

  • 采用WEB闭塞量表评估闭塞,在术后即刻及3、6、12个月随访进行。
  • 12个月时95%的治疗动脉瘤(n=20)达到充分闭塞。
  • 11%(n=5)的病例WEB植入技术失败。
  • 2例患者在术中发生血栓栓塞事件,无后遗损害。
  • 12个月观察期内无研究参与者因干预死亡。

临床应用与阅片要点

  • 作者认为WEB是安全的治疗选择,闭塞率与血管内血流导向装置相当且无需双联抗血小板治疗。
  • 术后即刻及3、6、12个月采用WEB闭塞量表评估闭塞情况。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The Woven EndoBridge is a device for endovascular embolization of intracranial aneurysms. The aim of this study is to re-evaluate this treatment method regarding its safety and efficacy and to compare it with the results of alternative treatment strategies (clipping, coiling, etc.) and their outcome known from the literature.

METHODS: Forty-four intracranial aneurysms treated with the Woven EndoBridge were retrospectively identified in a clinic for diagnostic and interventional neuroradiology. The average aneurysm height was 7.1 mm, and the average width was 5.8 mm. Further the average neck diameter (3.6 mm) and the average dome-to-neck ratio (1.6) were determined. Both ruptured and non-ruptured aneurysms were included in this study. Occlusion was assessed using the WEB Occlusion Scale immediately after the intervention and after three, six and twelve months follow-up.

RESULTS: In 11% of cases (n = 5), implantation of the Woven EndoBridge failed technically. In two patients, a thromboembolic event occurred during the intervention without consequential damage. During the observation period of twelve months, none of the study participants died because of the intervention. After twelve months, 95% of the treated aneurysms (n = 20) showed adequate occlusion.

CONCLUSION: Compared to other treatment strategies (clipping, coiling etc.) and their complication rates known from other studies, our results suggest that the Woven EndoBridge is a safe treatment option. Regarding the angiographic results, the Woven EndoBridge achieves occlusion rates which are comparable with those of intravascular flow diverters, but without the need of dual anti-platelet-aggregation therapy.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Gerdemann L, Reith W. Endovascular treatment of intracranial aneurysms with the Woven EndoBridge- safety and efficacy. Neuroradiology. 2025. PMID: 40498334. doi:10.1007/s00234-025-03673-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。